A Tertiary Amino-Containing Polymethacrylate Polymer Protects Mucus-Covered Intestinal Epithelial Monolayers Against Pathogenic Challenge
- First Online:
- 148 Downloads
We examined the cytoprotective influences of the mucoadhesive polymer, poly(DMAEMA), on human mucus-producing intestinal epithelial monolayers against two bacterial exotoxins and S. typhimurium. Direct anti-bacterial effects were also assessed against S. typhimurium.
In the presence and absence of mucus, untreated or poly(DMAEMA)-exposed monolayers were challenged with S. typhimurium or supernatants containing either cholera (CTx) or C. difficile toxins. Assays included LDH, cytokine secretion, cyclic AMP (cAMP) and microscopy to visualise bacterial adherence by monolayers. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of poly(DMAEMA) against S. typhimurium were established, along with a time–kill study.
CTx and C. difficile toxin induced LDH release from E12 monolayers. CTx also elevated intracellular epithelial cAMP, while S. typhimurium induced basolateral IL-8 secretion. Pre-treatment of E12 monolayers with poly(DMAEMA) reduced these effects, but only in the presence of mucus. The polymer co-localised with S. typhimurium in mucus and reduced bacteria–epithelia association. Poly(DMAEMA) was directly bactericidal against S. typhimurium at 1 mg/ml within 30 min.
Poly(DMAEMA) may have potential as a non-absorbed polymer therapeutic against infection. These effects were mediated by a combination of physical interaction with mucus and by direct bacterial killing.
Key wordsanti-bacterial polymers bacterial resistance HT29 monolayers living radical polymerisation poly(2-(dimethylamino-ethyl) methacrylate
minimum bactericidal concentration
minimum inhibitory concentration
- 7.M. G. Scott, E. Dullaghan, N. Mookherjee, N. Glavas, M. Waldbrook, A. Thompson, A. Wang, K. Lee, S. Doria, P. Hamill, J. J. Yu, Y. Li, O. Donini, M. M. Guarna, B. B. Finlay, J. R. North, and R. E. Hancock. An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25:465–472 (2007).PubMedCrossRefGoogle Scholar
- 8.A. Swidsinski, B. C. Sydora, Y. Doerffel, V. Loening-Baucke, M. Vaneechoutte, M. Lupicki, J. Scholze, H. Lochs, and L. A. Dieleman. Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiota. Inflamm. Bowel Dis. 13:963–970 (2007).PubMedCrossRefGoogle Scholar
- 10.D. M. Haddleton, M. C. Crossman, B. H. Ana, D. J. Duncalf, A. M. Heming, D. Kukulj, and A. J. Shooter. Atom transfer polymerization of methyl methacrylate mediated by alkylpyridylmethanimine type ligands, copper(I) bromide, and alkyl halides in hydrocarbon solution. Macromolecules 32:2110–2119 (1999).CrossRefGoogle Scholar
- 15.L. Wu, O. Zaborina, A. Zaborin, E. B. Chang, M. Musch, C. Holbrook, J. Shapiro, J. R. Turner, G. Wu, K. Y. Lee, and J. C. Alverdy. High-molecular-weight polyethylene glycol prevents lethal sepsis due to intestinal Pseudomonas aeruginosa. Gastroenterology 126:488–498 (2004).PubMedCrossRefGoogle Scholar
- 16.M. Werthen, M. Davoudi, A. Sonesson, D. P. Nitsche, M. Morgelin, K. Blom, and A. Schmidtchen. Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer. J. Antimicrob. Chemother. 54:772–779 (2004).PubMedCrossRefGoogle Scholar
- 26.Clinical and Laboratory Standards Institute. Methods for dilutionantimicrobial susceptibility tests for bacteria that grow aerobically;Approved Standard—Seventh Edition. CLSI document M7-A7. CLSI, Wayne, PA, USA. (2006).Google Scholar
- 27.National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents; Approved Guideline. NCCLS document M26-A. NCCLS, Wayne, PA, USA. (1999).Google Scholar
- 41.A. Haque, F. Bowe, R. J. Fitzhenry, G. Frankel, M. Thomson, R. Heuschkel, S. Murch, M. P. Stevens, T. S. Wallis, A. D. Phillips, and G. Dougan. Early interactions of Salmonella enterica serovar typhimurium with human small intestinal epithelial explants. Gut 53:1424–1430 (2004).PubMedCrossRefGoogle Scholar
- 42.K. Sakamoto, Y. Mori, H. Takagi, H. Iwata, T. Yamada, N. Futamura, T. Sago, T. Ezaki, Y. Kawamura, and H. Hirose. Translocation of Salmonella typhimurium in rats on total parenteral nutrition correlates with changes in intestinal morphology and mucus gel. Nutrition 20:372–376 (2004).PubMedCrossRefGoogle Scholar
- 48.S. M. Ryan, L. Tao, D. M. Haddleton, and D. J. Brayden. Oral polymeric conjugate system for salmon calcitonin: cytotoxicity studies. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 33:A870 (2006).Google Scholar